Oncogenes and tumour suppressor genes Flashcards
What were the original 6 hallmarks of cancer
Sustaining proliferative signalling Resisting cell death Inducing angiogenesis Enabling replicative immortality Activating invasion and metastasis Evading growth suppressors.
What are the emerging and enabling hallmarks
Emerging:
Deregulating cellular energetics- switch to the more energy dependent anaerobic respiration
Avoiding immune destruction.
Enabling:
Genome instability and mutation- to promote mutagenesis that leads to aberrant growth
Tumour-promoting infiltration.
Summarise the key features of the cell cycle
Cycle checkpoints (growth arrest ensures genetic fidelity).
Specific proteins accumulate/ are destroyed during the cycle.
Cyclins, cycle dependent kinases, cycle dependent kinase inhibitors
Permanent activation of a cyclin can drive a cell through a checkpoint.
Describe the G1-S checkpoint
Check for DNA damage
Restriction point: check for cell size and favourable environmental conditions (growth factor)
Describe the G2-M checkpoint
Check for damage or unduplicated DNA
Describe the metaphase checkpoint
Check for chromosome attachment to mitotic spindle.
What happens at these checkpoints
Cell cycle is arrested
If DNA damaged- tries to repair with DNA repair genes e.g BRCA
If damage too big- apoptosis.
Describe what is meant by proto-oncogenes
Proto-oncogenes code for essential proteins involved in maintenance of cell growth, division and differentiation.
Mutation converts a proto-oncogene to an oncogene, whose protein product no longer responds to control influences.
Oncogenes can be aberrantly expressed, over-expressed or aberrantly active.
E.g. MYC, RAS, ERB, SIS
Proto-oncogenes can be converted to an oncogene by a single mutation.
What is the key difference between photo-oncogenes and oncogenes
Proto-oncogene: code for essential proteins involved in maintenance of cell growth, division and differentiation e.g. Kinases, phosphorylases, transcription factors
Oncogene: mutations in proto-oncogenes that promote uncontrolled cell proliferation - aberrantly expressed, over-expressed (e.g. HER2) or aberrantly active
Describe how normal photo-oncogenes can be activated
The normal proto-oncogene can be activated in 4 ways:
1. Mutation in the coding sequence.
Point mutation or deletion.
2. Gene amplification.
A protein may block the DNA polymerase so the polymerase repeatedly backs up to go over the area a few times creating many identical genes.
3. Chromosomal translocation.
Chimeric genes.
4. Insertional mutagenesis.
Viral infections – some viruses insert their genome into our DNA and usually this isn’t a problem as much of our DNA does not code but if it’s in a coding region, this could be cancer.
What is the end result of gene amplification
You get multiple copies of the protein produced.
Problem with HER2 in Breast Cancers
What are Chimeric genes
Genes that are formed by combinations of portions of one or more coding sequence to produce new genes (e.g. the swapping of tips of chromosomes)
When can the formation of chimeric genes be problematic
If one of the pieces of translocated DNA is a promoter, it could lead to upregulation of the other gene portion (this occurs in Burkitt’s lymphoma)
If the fusion gene codes for an abnormal protein that promotes cancer
What is the Philadelphia chromosome
Chromosome produced by the translocation of the ABL gene on chromosome 9 to the BCR gene on chromosome 22
The BCR-ABL fusion gene encodes a protein that promotes the development of cancer
BCR is anti-apoptotic- so enables tumour to be resistance to stop signals.
Describe the two possible results of chromosomal translocation and insertional mutagenesis
Strong enhancer increases normal protein levels
e.g. Burkitt’s lymphoma- lose normal regulation of gene
Fusion to actively transcribed gene overproduces protein or fusion protein is hyperactive.
e.g. Philadelphia chromosome
Summarise the Philadelphia chromosome
Philadelphia chromosome: end of long arms of Chr9 and Chr22 exchanged to form the BCR-ABL fusion protein - ABL is a very strong promotor region
Summarise the signal transduction pathways
Steroid hormone- Nuclear or cytosolic receptor — transcription/translation — proliferation
Tyrosine Kinase receptor — ligand binds — phosphorylation — proliferation
GPCR- kinase- phosphorylation – proliferaation
Proteins involved in signal transduction are potential critical gene targets (proto-oncogenes)
Activation of proto-oncogenes to oncogenes disrupts normal activity
Give some examples of signal transduction proteins that are photo-oncogenes
Signal transduction proteins are proto-oncogenes.
Examples:
o Tyrosine kinase receptors EC – met, neu.
o Tyrosine kinase receptors IC – src, ret.
o Transcription factors – myc, fos, jun.
o GPCR g-proteins – ras, gip-2.
o Kinases – raf, pim-1.
May habe a point mutation which changes conformation - so inhibitory proteins cannot bind
or changes phosphorylation residues- such that it’s constitutively active.
The higher up the pathway the mutation is- the harder it is to treat- due to a greater dysregulaiton of downstream pathways.